Keros Therapeutics, Inc. (KROS)
Keros Therapeutics, Inc. (KROS) has a 21-report earnings history dating back to May 06, 2021. Its average absolute post-earnings move is ±5.37%, and 38.1% of those reactions were positive. Its largest post-earnings gain was +27.69% (Nov 04, 2021) and its largest decline was -14.96% (Mar 04, 2026). The next earnings report is predicted for 2026-08-06 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±5.37%
Positive %
38.1%
Negative %
61.9%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | ☀ PRE | $11.62 | $11.72 | $10.98 | 45,598 | -8.5% | open_in_new |
| Mar 04, 2026 | ☽ POST | $13.43 | $13.85 | $13.77 | 369,000 | -14.96% | open_in_new |
| Nov 05, 2025 | ☽ POST | $15.52 | $15.69 | $15.65 | 1,262,300 | +3.32% | open_in_new |
| Aug 06, 2025 | ☽ POST | $14.26 | $14.42 | $14.41 | 375,300 | -7.29% | open_in_new |
| May 06, 2025 | ☽ POST | $14.45 | $14.50 | $13.76 | 1,083,200 | -0.36% | open_in_new |
| Feb 26, 2025 | ☽ POST | $10.94 | $11.18 | $10.94 | 1,491,200 | +0.64% | open_in_new |
| Nov 06, 2024 | ☽ POST | $65.00 | $66.99 | $66.45 | 535,800 | +1.08% | open_in_new |
| Aug 07, 2024 | ☽ POST | $49.29 | $49.29 | $45.40 | 222,600 | -2.18% | open_in_new |
| May 08, 2024 | ☀ PRE | $56.56 | $59.75 | $58.24 | 230,100 | -0.75% | open_in_new |
| Feb 28, 2024 | ☽ POST | $69.71 | $70.69 | $68.07 | 277,900 | -0.84% | open_in_new |
| Nov 06, 2023 | ☀ PRE | $32.67 | $34.25 | $31.69 | 237,700 | -0.78% | open_in_new |
| Aug 07, 2023 | ☀ PRE | $41.95 | $41.95 | $40.42 | 175,500 | -1.73% | open_in_new |
| May 04, 2023 | ☽ POST | $44.97 | $46.24 | $45.52 | 143,500 | -3.08% | open_in_new |
| Mar 03, 2023 | ☽ POST | $56.07 | $59.96 | $59.32 | 316,700 | -12% | open_in_new |
| Nov 03, 2022 | ☀ PRE | $49.05 | $50.87 | $50.46 | 207,200 | +1.69% | open_in_new |
| Aug 04, 2022 | ☽ POST | $33.17 | $33.75 | $33.12 | 319,000 | +12.77% | open_in_new |
| May 05, 2022 | ☀ PRE | $52.03 | $53.28 | $50.49 | 152,600 | -7.22% | open_in_new |
| Mar 09, 2022 | ☽ POST | $51.27 | $55.27 | $53.96 | 139,200 | +0.85% | open_in_new |
| Nov 04, 2021 | ☀ PRE | $41.01 | $55.54 | $53.08 | 467,200 | +27.69% | open_in_new |
| Aug 05, 2021 | ☽ POST | $34.20 | $35.05 | $34.97 | 94,900 | +2.83% | open_in_new |
| May 06, 2021 | ☽ POST | $54.24 | $55.56 | $54.35 | 87,900 | -2.28% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±5.37%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 144 | 20260604 | open_in_new SEC.gov |
| 144 | 20260604 | open_in_new SEC.gov |
Frequently asked about KROS earnings
When does Keros Therapeutics, Inc. report earnings next? expand_more
Keros Therapeutics, Inc. (KROS)'s next earnings date is approximate for 2026-08-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does KROS stock move after earnings? expand_more
Over 21 reports, KROS has moved an average of ±5.37% the session after earnings, closing higher 38.1% of the time.
What was KROS's biggest post-earnings move? expand_more
KROS's largest post-earnings gain on record was +27.69% on Nov 04, 2021, and its largest decline was -14.96% on Mar 04, 2026.
Where can I find Keros Therapeutics, Inc.'s SEC filings? expand_more
All of Keros Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right